ILA 30.9
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.73 Million ILS | -71.19% |
2022 | 6.01 Million ILS | 20.52% |
2021 | 4.99 Million ILS | 346.69% |
2020 | 1.11 Million ILS | 257.19% |
2019 | 313 Thousand ILS | 35.5% |
2018 | 231 Thousand ILS | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 7.52 Million ILS | 0.0% |
2023 FY | 1.73 Million ILS | -71.19% |
2023 Q2 | 6.65 Million ILS | 0.0% |
2023 Q4 | 1.73 Million ILS | 0.0% |
2022 Q4 | 6.01 Million ILS | 0.0% |
2022 Q2 | 5.92 Million ILS | 0.0% |
2022 FY | 6.01 Million ILS | 20.52% |
2021 Q4 | 4.99 Million ILS | 0.0% |
2021 FY | 4.99 Million ILS | 346.69% |
2021 Q2 | 4.03 Million ILS | 0.0% |
2020 Q3 | 1.11 Million ILS | 227.86% |
2020 Q1 | 341 Thousand ILS | 8.95% |
2020 FY | 1.11 Million ILS | 257.19% |
2020 Q4 | 1.11 Million ILS | 0.0% |
2020 Q2 | 341 Thousand ILS | 0.0% |
2019 FY | 313 Thousand ILS | 35.5% |
2019 Q4 | 313 Thousand ILS | 0.0% |
2019 Q3 | 313 Thousand ILS | 0.0% |
2019 Q1 | - ILS | 0.0% |
2018 FY | 231 Thousand ILS | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
C-Lab Ltd | 3.62 Billion ILA | 99.952% |